BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
9.09
-0.04 (-0.44%)
Mar 13, 2026, 4:00 PM EDT - Market closed

BBOT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
727792247--
Market Cap Growth
189.21%220.82%---
Enterprise Value
304.8368.7414.5700
Last Close Price
9.099.9010.50--
PE Ratio
--2.300.00--
PB Ratio
1.771.93-1.38--
P/TBV Ratio
0.690.750.00--
P/FCF Ratio
--6.92-4.48--
P/OCF Ratio
--6.95-4.49--
EV/EBITDA Ratio
--2.54-5.14--
EV/EBIT Ratio
--2.53-5.13--
EV/FCF Ratio
--3.22-7.53--
Debt / Equity Ratio
0.010.01000
Debt / EBITDA Ratio
-0.02-0.02---
Debt / FCF Ratio
-0.02-0.02---
Net Debt / Equity Ratio
-1.03-1.030.87--
Net Debt / EBITDA Ratio
2.912.911.93--
Net Debt / FCF Ratio
3.693.692.83--
Quick Ratio
12.1512.157.9500
Current Ratio
12.3412.348.1000
Return on Equity (ROE)
-115.33%-115.33%83.13%97.59%16.09%
Return on Assets (ROA)
-47.60%-47.60%-98.23%-17.46%-2.43%
Return on Invested Capital (ROIC)
1622.01%1622.01%2365.07%-18.03%-2.43%
Return on Capital Employed (ROCE)
-52.26%-52.26%-111.80%97.59%16.09%
Earnings Yield
-18.43%-43.43%-54822.95%--
FCF Yield
-15.74%-14.46%-22.31%--
Buyback Yield / Dilution
-47.16%-47.16%-0.45%--
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.